LIN7A
Protein lin-7 homolog A
Also known as: LIN-7A, LIN7A_HUMAN, MALS-1, TIP-33, VELI1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14910
- Gene
- LIN7A
- Ensembl
- ENSG00000111052
- Chromosome
- 12
- Canonical length
- 233 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is involved in generating and maintaining the asymmetric distribution of channels and receptors at the cell membrane. The encoded protein also is required for the localization of some specific channels and can be part of a protein complex that couples synaptic vesicle exocytosis to cell adhesion in the brain. [provided by RefSeq, May 2016]
Canonical amino-acid sequenceUniProt
233 residues, UniProt reviewed canonical sequence.
>O14910|LIN7A
1 MLKPSVTSAP TADMATLTVV QPLTLDRDVA RAIELLEKLQ ESGEVPVHKL QSLKKVLQSE
61 FCTAIREVYQ YMHETITVNG CPEFRARATA KATVAAFAAS EGHSHPRVVE LPKTDEGLGF
121 NVMGGKEQNS PIYISRIIPG GVAERHGGLK RGDQLLSVNG VSVEGEHHEK AVELLKAAKD
181 SVKLVVRYTP KVLEEMEARF EKLRTARRRQ QQQLLIQQQQ QQQQQQTQQN HMSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LIN7A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 26 nTPM
- retina: 25 nTPM
- cerebellum: 19 nTPM
- liver: 17 nTPM
- kidney: 8.1 nTPM
- endometrium: 7.9 nTPM
Single-cell type
- neutrophils: 714 nCPM
- neutrophil progenitors: 687 nCPM
- retinal bipolar cells: 290 nCPM
- bergmann glia: 258 nCPM
- renal collecting duct intercalated cells: 253 nCPM
- lactotrophs: 237 nCPM
Immune cell
- neutrophil: 30 nTPM
- basophil: 19 nTPM
- eosinophil: 16 nTPM
- classical monocyte: 5.2 nTPM
- total PBMC: 1.2 nTPM
- intermediate monocyte: 0.8 nTPM
Brain region
- cerebellum: 53 nTPM
- cerebral cortex: 23 nTPM
- midbrain: 21 nTPM
- thalamus: 21 nTPM
- basal ganglia: 20 nTPM
- hypothalamus: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.2
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- exocytosis
- inner ear development
- neurotransmitter secretion
- protein transport
- protein-containing complex assembly
- regulation of synaptic assembly at neuromuscular junction
- synaptic vesicle transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LIN7A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LIN7A as an antibody target. Whether an autoantibody or antibody against LIN7A could matter depends on whether native LIN7A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LIN7A is annotated at the cell surface, where native LIN7A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LIN7A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...